CEA-delta could be a biomarker of tumor phenotype, clinical stage, and chemotherapeutic response in rectal cancer with OCT4-positive cancer stem cells

BACKGROUND: There is very limited evidence on biomarkers for evaluating the clinical behavior and therapeutic response in rectal cancer (RC) with positive expression of cancer stem cells (CSCs). METHODS: An exploratory prospective study was conducted, which included fresh samples of tumor tissue fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Lozada-Martinez, Ivan David, Bolaño-Romero, Maria Paz, Lambis-Anaya, Lina, Liscano, Yamil, Suarez-Causado, Amileth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514348/
https://www.ncbi.nlm.nih.gov/pubmed/37746252
http://dx.doi.org/10.3389/fonc.2023.1258863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514348/
https://www.ncbi.nlm.nih.gov/pubmed/37746252
http://dx.doi.org/10.3389/fonc.2023.1258863

Ejemplares similares